SKYSEQ Trademark

Trademark Overview

On Friday, March 19, 2021, a trademark application was filed for SKYSEQ with the United States Patent and Trademark Office. The USPTO has given the SKYSEQ trademark a serial number of 90590474. The federal status of this trademark filing is SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, November 1, 2024. This trademark is owned by Skyhawk Therapeutics, Inc.. The SKYSEQ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases using integrated and high-throughput screening technologies coupled with next-generation sequencing
skyseq

General Information

Serial Number90590474
Word MarkSKYSEQ
Filing DateFriday, March 19, 2021
Status814 - SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, November 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2022

Trademark Statements

Goods and ServicesResearch and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases using integrated and high-throughput screening technologies coupled with next-generation sequencing

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 22, 2021
Primary Code042
First Use Anywhere DateMonday, April 8, 2024
First Use In Commerce DateMonday, April 8, 2024

Trademark Owner History

Party NameSkyhawk Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameSkyhawk Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Wednesday, October 27, 2021PRIORITY ACTION E-MAILED
Tuesday, March 23, 2021NEW APPLICATION ENTERED
Tuesday, June 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 21, 2021ASSIGNED TO EXAMINER
Wednesday, October 27, 2021PRIORITY ACTION WRITTEN
Wednesday, October 27, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, April 26, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 15, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 5, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 22, 2023SOU EXTENSION 1 FILED
Wednesday, February 22, 2023SOU EXTENSION 1 GRANTED
Friday, February 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 21, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 21, 2023SOU EXTENSION 2 FILED
Monday, August 21, 2023SOU EXTENSION 2 GRANTED
Wednesday, August 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 19, 2024SOU TEAS EXTENSION RECEIVED
Monday, February 19, 2024SOU EXTENSION 3 FILED
Monday, February 19, 2024SOU EXTENSION 3 GRANTED
Tuesday, February 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 28, 2024USE AMENDMENT FILED
Tuesday, May 28, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, July 6, 2024STATEMENT OF USE PROCESSING COMPLETE
Saturday, July 6, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 27, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 18, 2024NON-FINAL ACTION E-MAILED
Friday, October 18, 2024SU - NON-FINAL ACTION - WRITTEN
Friday, October 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 1, 2024ASSIGNED TO LIE

Related Keywords

skyseq diseases high integrated using infectious other throughput screening sequencing generation